Quarterly report [Sections 13 or 15(d)]

Note 11 - Stock Based Compensation - Stock Option Activity (Details)

v3.25.2
Note 11 - Stock Based Compensation - Stock Option Activity (Details) - The 2023 Equity Plan [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Outstanding (in shares) 492,500 442,500 500,500 442,500
Outstanding, weighted average exercise price (in dollars per share) $ 9.59 $ 9.36 $ 9.59 $ 9.36
Granted, options (in shares) 0 0 0 0
Granted, weighted average exercise price (in dollars per share) $ 0 $ 0 $ 0 $ 0
Exercised, options (in shares) 0 0 0  
Exercised, weighted average exercise price (in dollars per share) $ 0 $ 0 $ 0  
Forfeited, options (in shares) 2,000 0 10,000 0
Forfeited, weighted average exercise price (in dollars per share) $ 9.36 $ 0 $ 9.36 $ 0
Outstanding (in shares) 490,500 442,500 490,500 442,500
Outstanding, weighted average exercise price (in dollars per share) $ 9.59 $ 9.36 $ 9.59 $ 9.36
Outstanding, aggregate intrinsic value [1] $ 1,344 [2] $ 96 $ 1,344 [2] $ 96
Exercisable, options (in shares) 186,800 111,500 186,800 111,500
Exercisable, weighted average exercise price (in dollars per share) $ 9.36 $ 9.36 $ 9.36 $ 9.36
Exercisable, aggregate intrinsic value [1],[2] $ 555 $ 30 $ 555 $ 30
[1] Dollars in thousands. The aggregate intrinsic value of outstanding and exercisable options at March 31, 2025 and 2024 were calculated based on the closing market price of the Company's common stock of March 31, 2025 and 2024 of $11.29 and $9.54, respectively, per share less the exercise price.
[2] Dollars in thousands. The aggregate intrinsic value of outstanding and exercisable options at September 30, 2023 and 2024 were calculated based on the closing market price of the Company's common stock of September 30, 2023 and 2024 of $10.35 and $9.05, respectively, per share less the exercise price.